Results 281 to 290 of about 1,839,456 (290)

Effect of TP53 mutation, expression and polymorphism on the survival, immune infiltration and ferroptosis in patients with prostate cancer. [PDF]

Oncol Lett
Wen GM, Zhao ZY, Zheng XH, Liu DH, Xia P.   +4 more
europepmc   +1 more source

Optimizing therapy for high-risk biochemically recurrent non-metastatic prostate cancer Current and emerging strategies. [PDF]

Can Urol Assoc J
Kollmannsberger C, Finelli A, Loblaw A, Niazi T, Pouliot F, Rendon RA, Shayegan B, Saad F.   +7 more
europepmc   +1 more source

AI-driven online adaptive radiotherapy in prostate cancer treatment: considerations on activity time and dosimetric benefits. [PDF]

Radiat Oncol
Preziosi F, Boschetti A, Catucci F, Votta C, Vellini L, Menna S, Quaranta F, Pilloni E, D'Aviero A, Aquilano M, Di Dio C, Iezzi M, Re A, Piras A, Marras M, Gruosso F, Piro D, Piccari D, Tagliaferri L, Gambacorta MA, Indovina L, Mattiucci GC, Cusumano D.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prostate cancer

Nature Reviews Disease Primers, 2021
R. Rebello, C. Oing, K. Knudsen, S. Loeb, David C. Johnson, R. Reiter, S. Gillessen, T. H. van der Kwast, R. Bristow   +8 more
semanticscholar   +1 more source

The polycomb group protein EZH2 is involved in progression of prostate cancer

Nature, 2002
S. Varambally, S. Dhanasekaran, Ming Zhou, T. Barrette, Chandan Kumar-Sinha, M. Sanda, D. Ghosh, K. Pienta, R. Sewalt, A. Otte, M. Rubin, A. Chinnaiyan   +11 more
semanticscholar   +1 more source

The Diagnosis and Treatment of Prostate Cancer: A Review

Journal of the American Medical Association (JAMA), 2017
M. Litwin, Hung-Jui Tan
semanticscholar   +1 more source

The development of androgen-independent prostate cancer

Nature Reviews. Cancer, 2001
B. Feldman, D. Feldman
semanticscholar   +1 more source